These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1399540)

  • 1. Metabolic changes in bone in old age.
    Pratelli L; Ravaglia G; Ciapetti G; Pizzoferrato A
    Ital J Orthop Traumatol; 1992; 18(1):95-105. PubMed ID: 1399540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sex and age on biochemical bone metabolism parameters.
    Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
    Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin reserve and the differentiated response to calcitonin in osteoporosis.
    Vlăduţiu T; Lopez A; Gozariu L; Barabaş E
    Endocrinologie; 1990; 28(3-4):139-47. PubMed ID: 2103972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis.
    Cecchettin M; Bellometti S; Cremonesi G; Solimeno LP; Torri G
    Biomed Pharmacother; 1995; 49(10):465-8. PubMed ID: 8746073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.
    Riggs B; Jowsey J; Kelly PJ; Arnaud CD
    Boll Soc Ital Biol Sper; 1973 Jul; 49(12):732-7. PubMed ID: 4364781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the biological diagnosis of osteoporosis].
    Rev Clin Esp; 1972 May; 125(4):375-6. PubMed ID: 5080184
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of bone mineral content in osteoporosis].
    Nishizawa Y; Miki T; Nakatsuka K; Hagiwara S; Iba K; Morii H
    Nihon Ronen Igakkai Zasshi; 1992 Apr; 29(4):257-61. PubMed ID: 1614003
    [No Abstract]   [Full Text] [Related]  

  • 11. Deficiency of calcitonin in age related osteoporoses.
    Milhaud G; Benezech-Lefevre M; Moukhtar MS
    Biomedicine; 1978 Nov; 29(8):272-6. PubMed ID: 556387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in calcium regulating hormone in osteoporosis].
    Okamoto Y; Ota K
    Nihon Rinsho; 1994 Sep; 52(9):2295-300. PubMed ID: 7967071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of biochemical markers of bone turnover in diagnosis of osteoporosis].
    Pluskiewicz W; Stempniewicz E
    Przegl Lek; 1994; 51(3):149-51. PubMed ID: 8058983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Androgens and bone metabolism. Significance in osteoporosis in man and woman].
    Kasperk CH; Ziegler R
    Dtsch Med Wochenschr; 1992 Jun; 117(25):990-6. PubMed ID: 1611969
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of age on some blood variables relating to bone metabolism in women.
    Willig R; Jalovaara P
    Int J Surg Investig; 2000; 1(6):495-502. PubMed ID: 11729857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bone turnover in the pathophysiology of osteoporosis.
    Riis BJ
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():9-14; discussion 14-5. PubMed ID: 8624350
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
    Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G
    J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiology and risk factors of involutional osteoporosis].
    Orimo H; Kaneki M
    Nihon Rinsho; 1990 Dec; 48(12):2862-6. PubMed ID: 2086846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.